The magnetostructural
properties of the arrays can be controlled by post-annealing, where the magnetization is proportional to the annealing temperature. The electroless-plated arrays synthesized in this work display magnetic anisotropy not found in electroplated ones. This is likely attributed to the nature of the clusterlike microstructure, whose cluster-boundaries may confine the FM rotation within the cluster. The spin-polarization was probed by x-ray magnetic circular dichroism while the arrays underwent the SM Selleck RG-7388 -> FM phase transition. The sum-rules results reveal that the total magnetization of the arrays is dominated by spin moment (m(spin)). The change in m(spin) is responsible for the SM -> FM phase transition upon annealing, as well as for the loss of magnetization upon temperature increase that we observed macroscopically. VC 2011 American buy AG-881 Institute of Physics. [doi:10.1063/1.3594692]“
“Breast cancer is a common
cancer in women, with a highly variable course, from inoffensive to lethal. To find a more effective strategy for its treatment, sodium valproate has been tested as an anti-cancer drug; it is the only clinically available histone deacetylase inhibitor. However, data about the effects of sodium valproate
on breast cancer are insufficient in both animals and humans; studies have yielded conflicting conclusions. In particular, little is known about the check details association between expression of the metastasis suppressor Nm23H1 gene and breast cancer. We hypothesized that sodium valproate regulates NM23H1 expression, and affects migration and/or invasion. We found that sodium valproate at concentrations of 0.8-3.2 mM inhibits migration and modulates Nm23H1 gene expression in a concentration-dependent manner. Confluent MDA-MB-231 cells were scratched by a micropipette tip after VPA treatment for 24 h; 24 h later, the scratch was almostly closed in the 0 mM VPA-treated cells, while the 3.2 mM VPA-treated cells migrated the slowest. The cell migration ratio exposed to 0.8, 1.6 and 3.2 mM VPA was about 66.67, 30.67 and 26.67% (P < 0.05). We also found evidence that sodium valproate upregulates NM23H1 expression, which is a clue to its anti-cancer mode of action. The NM23H1 gene expression was relative fold increased determined by Western blotting at 3.2 mM VPA. Collectively, these observations indicate that sodium valproate has potential for use in breast cancer treatment.